Research Article

New Evidence for Artemisia absinthium L. Application in Gastrointestinal Ailments: Ethnopharmacology, Antimicrobial Capacity, Cytotoxicity, and Phenolic Profile

Table 4

Antibacterial activity of A. absinthium L. ethanolic extract.

BacteriaA. absinthium (mg/mL)Streptomycin (µg/mL)
MICMBCMICMBC

Micrococcus luteus (dT_9/2)0.51.06.212.5
Rothia mucilaginosa (oT_22/2)0.51.012.525
Streptococcus agalactiae (oT_20/1)1.02.03.16.2
Streptococcus anginosus (oT_26)2.04.03.16.2
Streptococcus dysgalactiae (oT_21/2)0.51.06.212.5
Streptococcus oralis (oT_5)1.02.012.525
Streptococcus parasanguinis (oT_3)0.51.03.16.2
Streptococcus pyogenes (dT_14)2.04.03.16.2
Streptococcus pyogenes (IBR S004)1.02.014.028.0
Streptococcus salivarius (dT_12)0.20.56.212.5
Streptococcus salivarius (IBR S006)1.02.03.87.6
Enterococcus faecalis (IBR E001)0.51.050.0100.0
Staphylococcus hominis (oT_14/2)2.04.037.575.0
MRSA (IBRS MRSA 011)4.08.0100>100
Listeria monocytogenes (NCTC 7973)4.08.050.0100
Enterobacter cloacae (oT_18)0.51.037.575
Enterobacter cloacae (ATCC 35030)0.51.025.050.0
Stenotrophomonas maltophilia (A_12)2.04.037.575.0
Pseudomonas aeruginosa (IBRS P001)1.02.050.0100.0
Yersinia enterocolitica (ATCC 23715)1.02.010.020.0
Klebsiella pneumoniae (ATCC 13883)1.02.05.010.0
Salmonella enterica (ATCC 13311)1.02.050.0100.0
Escherichia coli (IBRS E003)4.08.0100>100
Escherichia coli (ATCC 35210)1.02.050.0100

MIC: minimal inhibitory concentration and MBC: minimal bactericidal concentration. Results are in mg/mL.